Principal Scientist Targeted Protein Degradation - (Chicago, IL)

Date: Jan 3, 2019 Location:Boston, Massachusetts, US Principal Scientist – Targeted Protein Degradation Bedford, MA Beryllium is a wholly owned subsidiary of UCB and integral to the UCB New Medicines R&D organization. UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases in immunology and neurology. Beryllium provides innovative strategies and solutions in protein biochemistry, structural biology and cell biology to perform novel drug discovery. Our Bedford, MA facility has openings for several Senior Research Scientists in Functional Biology. The successful applicants will have a background in both cell based and biochemical assays with direct background with developing and optimizing assays across different formats. Key responsibilities: Design and execution of functional biology approaches to evaluate targeted protein degradation.